Merck KGaA
Content by Merck KGaA
Merck KGaA has not yet contributed any content.
June 2025, Issue 1
Nergal Networks: Where Friendship Meets Infection
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this IssueResearch Resources
Enhancing Elution of Plasmid DNA
An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.
Maximizing Lentivirus Recovery
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
Overcoming Obstacles in Plasmid DNA Manufacturing
Discover a scalable and flexible GMP-compliant workflow for producing plasmid DNA.
Unraveling Complex Biology with Five-Dimensional Multiomics
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
Products
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity
Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security.
Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
Agilent Announces the Enhanced 8850 Gas Chromatograph
Compact, Powerful, and now Mass Spec-Connected for Superior Analytical Performance
Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.